Literature DB >> 17855772

Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.

Utpal Sen1, Neetu Tyagi, Munish Kumar, Karni S Moshal, Walter E Rodriguez, Suresh C Tyagi.   

Abstract

Although elevated levels of homocysteine (Hcy) known as hyperhomocysteinemia (HHcy) are associated with increased inflammation and vascular remodeling, the mechanism of Hcy-mediated inflammation and vascular remodeling is unclear. The matrix metalloproteinases (MMPs) and adhesion molecules play an important role in vascular remodeling. We hypothesized that HHcy induces inflammation by increasing adhesion molecules and matrix protein expression. Endothelial cells were supplemented with high methionine, and Hcy accumulation was measured by HPLC. Nitric oxide (NO) bioavailability was detected by a NO probe. The protein expression was measured by Western blot analysis. MMP-9 activity was detected by gelatin-gel zymography. We demonstrated that methionine supplement promoted upregulation of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) through increased Hcy accumulation. In addition, increased synthesis of collagen type-1 was also observed. MMP-9 gene expression and protein activity were increased in methionine supplement groups. 3-Deazaadenosine (DZA), an adenosine analogue, prevented high methionine-induced ICAM-1 and VCAM-1 expression and collagen type-1 synthesis. Transfection of endothelial cells with cystathionine-beta-synthase (CBS) gene construct, which converts Hcy to cystathionine, reduced Hcy accumulation in high methionine-fed cells. CBS gene transfection reduced the inflammatory response, as evident by attenuated ICAM-1 and VCAM-1 expression. Furthermore, collagen type-1 expression and MMP-9 activity were dramatically attenuated with CBS gene transfection. These results suggested that methionine supplement increased Hcy accumulation, which was associated with inflammatory response and matrix remodeling such as collagen type-1 synthesis and MMP-9 activity. However, in vitro DZA and CBS gene therapy successfully treated the HHcy-induced inflammatory reaction in the methionine metabolism pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855772     DOI: 10.1152/ajpcell.00207.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  28 in total

1.  Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction.

Authors:  Young-Rae Kim; Cuk-Seong Kim; Asma Naqvi; Ajay Kumar; Santosh Kumar; Timothy A Hoffman; Kaikobad Irani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

2.  Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc.

Authors:  Cuk-Seong Kim; Young-Rae Kim; Asma Naqvi; Santosh Kumar; Timothy A Hoffman; Saet-Byel Jung; Ajay Kumar; Byeong-Hwa Jeon; Dennis M McNamara; Kaikobad Irani
Journal:  Cardiovasc Res       Date:  2011-09-20       Impact factor: 10.787

3.  Hyperhomocysteinemia decreases intestinal motility leading to constipation.

Authors:  S Givvimani; C Munjal; N Narayanan; F Aqil; G Tyagi; N Metreveli; S C Tyagi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

4.  Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.

Authors:  Neetu Tyagi; Jonathan C Vacek; Srikanth Givvimani; Utpal Sen; Suresh C Tyagi
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

5.  Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia.

Authors:  Rui-xue Yang; Shan-ying Huang; Fang-fang Yan; Xiao-ting Lu; Yi-fan Xing; Yan Liu; Yun-fang Liu; Yu-xia Zhao
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

6.  Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction.

Authors:  Sathnur B Pushpakumar; Gustavo Perez-Abadia; Chirag Soni; Rong Wan; Nathan Todnem; Phani K Patibandla; Tathyana Fensterer; Qunwei Zhang; John H Barker; Claudio Maldonado
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

7.  Role of copper and homocysteine in pressure overload heart failure.

Authors:  William M Hughes; Walter E Rodriguez; Dorothea Rosenberger; Jing Chen; Utpal Sen; Neetu Tyagi; Karni S Moshal; Thomas Vacek; Y James Kang; Suresh C Tyagi
Journal:  Cardiovasc Toxicol       Date:  2008       Impact factor: 3.231

8.  Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.

Authors:  Paras K Mishra; Neetu Tyagi; Utpal Sen; Irving G Joshua; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2010-09-09       Impact factor: 9.951

Review 9.  Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator.

Authors:  Utpal Sen; Sathnur B Pushpakumar; Matthew A Amin; Suresh C Tyagi
Journal:  Nitric Oxide       Date:  2014-06-22       Impact factor: 4.427

10.  Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.

Authors:  Utpal Sen; Walter E Rodriguez; Neetu Tyagi; Munish Kumar; Soumi Kundu; Suresh C Tyagi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.